OBJECTIVES: Hyper-low-density lipoprotein (LDL)-cholesterolaemia is a potent risk factor for coronary atherosclerosis. We have recently demonstrated that a cluster of risk factors including insulin resistance, glucose intolerance, hypertriglyceridaemia, and hypertension based on intra-abdominal visceral fat accumulation are closely related to coronary artery disease. In the current study, we evaluated the relationship between visceral fat accumulation and the severity and distribution of coronary atherosclerosis in familial hypercholesterolaemia (FH). DESIGN: The effect of visceral fat accumulation on coronary lesions and risk factors in patients with FH was investigated. SUBJECTS: Thirty-one male patients with heterozygous FH who underwent coronary angiography. MEASUREMENTS: Abdominal fat distribution was estimated by a cross-sectional computed tomographic scan at the umbilical level. Plasma lipid, glucose and insulin concentrations and blood pressure were measured. A 75 g oral glucose tolerance test was also performed. RESULTS: The patients were divided into two groups according to the degree of visceral fat accumulation. Fifteen patients had high visceral fat accumulation (High VF group) and 16 patients had normal visceral fat accumulation (Normal VF group). Body mass index (BMI) and subcutaneous fat area were signi®cantly higher in the high VF group. Baseline serum triglyceride was signi®cantly higher and baseline low-density lipoprotein (LDL)-cholesterol and reduction of LDL-cholesterol during treatment were signi®cantly lower in High VF group. Fasting plasma glucose and insulin concentrations, and systolic and diastolic pressures were signi®cantly higher in the High VF group. Signi®cant correlations were found between visceral fat area and the sum of the glucose and insulin concentration during an oral glucose tolerance test. Visceral fat area was signi®cantly correlated with the severity of coronary stenosis index. Distal coronary lesions were signi®cantly more frequent in the High VF group. moreover, the correlation between the visceral fat area and coronary stenosis index was found to be independent of age, BMI, and subcutaneous fat area by multiple regression analysis. CONCLUSIONS: Visceral fat accumulation is a potent cardiovascular risk factor in heterozygous FH.
Introduction
Familial hypercholesterolaemia (FH) is an autosomal dominant disorder characterised by high plasma lowdensity lipoprotein (LDL)-cholesterol levels resulting from low LDL receptor activity. 1 This disease is often accompanied by premature coronary artery disease (CAD). 2, 3 The incidence of CAD in heterozygous FH is markedly higher than in the general population. We have previously demonstrated that the prevalence of CAD in male and female Japanese patients with FH over 40 y of age was 56% and 34%, respectively. 4 Although elevated LDL-cholesterol level is a substantial atherogenic risk in FH, the epidemiological studies by the research group on primary hyperlipidaemia, funded by the Japanese Ministry of Health and Welfare, found that hypertriglyceridaemia was also closely related to the development of CAD in patients with FH. 4±6 Accordingly, risk factors other than hyper-LDL-cholesterolaemia may play an important role in the development of CAD in patients with FH. In recent years, it has been shown that a cluster of multiple risk factors including glucose intolerance, insulin resistance, hypertriglyceridaemia, and hypertension, is closely related to atherosclerotic disease. 7, 8 Abdominal obesity has been found to be related to the appearance of these risk factors. 9±12 Furthermore, longitudinal studies have shown abdominal fat accumulation estimated by waist-to-hip ratio to be a signi®cant risk factor for cardiovascular disease and related death. 13, 14 Several recent studies have suggested that intra-abdominal fat accumulation is particularly crucial in these relationships. 15±20 Consequently, we have proposed the term`visceral fat syndrome', in reference to a highly atherogenic state associated with a cluster of risk factors based on visceral fat accumulation. 20 In this current study, we have examined abdominal fat distribution and other risk factors in patients with heterozygous FH and performed coronary angiography to assess whether visceral fat accumulation may be a determining factor for the severity of coronary atherosclerosis in FH.
Methods

Subjects
The subjects for this study were male patients with heterozygous FH who were admitted to the Second Department of Internal Medicine, Osaka University Hospital for the purpose of evaluation of metabolic and clinical pro®les and of suspected coronary atherosclerosis. Thirty-one male patients aged 52 AE 9 y (range 31±74 y) with an average BMI value of 25.0 AE 2.0 (range 20.1±28.4) were subjects in this study. The diagnosis of FH was based on the following criteria: 21, 22 (1) primary hypercholesterolaemia of more than 6.72 mmol/L and an increase in Achilles' tendon thickness (ATT ! 9 mm) determined by xeroradiography or computerized radiography or (2) primary hypercholesterolaemia of more than 6.72 mmol/ L and at least one ®rst degree relative with hypercholesterolaemia and Achilles' tendon xanthomas. The LDL receptor activity assay from cultured skin ®bro-blasts was performed to con®rm the diagnosis, in which the less than 80% of control was designated to be a FH. 22 Eight patients had a history of myocardial infarction, nine patients had stable angina pectoris and ®ve patients had signi®cant coronary lesions without symptoms (silent myocardial ischemia). The remaining nine patients did not have any symptoms or signi®cant coronary lesions. We have previously demonstrated that a substantial number of asymptomatic middle-aged male patients with FH have signi®cant coronary lesions by coronary angiography. 23 Twenty-eight patients were taking lipid-lowering agents at the start of the study: seven were treated with statin singly (pravastatin or sinvastatin), one with probucol singly, 13 combined with statin and probucol, three combined with statin and beza®brate, and four combined with statin, probucol, and cholestyramine.
Body fat distribution
The body fat distribution was determined with patients in the supine position using computed tomography (TCT-900S Helix CT/T scanner, Toshiba Medical Electronics Co. Ltd., Tokyo, Japan) according to our previously described procedure. 24 The subcutaneous fat layer was clearly and easily de®ned as the extraperitoneal fat between skin and muscle, with the attenuation ranging from 740 to 7140
House®eld units (HU). Intraperitoneal tissue with the same density as the subcutaneous fat layer was de®ned as the visceral fat area (VFA). The subcutaneous fat area (SFA) and intra-abdominal VFA were measured at the level of umbilicus. The ratio of the VFA to the SFA (V/S ratio) was calculated as an index of the relative increase of visceral fat. Patients were divided into two groups according to the following criteria: high visceral fat accumulation (High VF group); V/S ratio ! 0.4 in obese (BMI ! 26.4) and VFA ! 100 cm 2 in non-obese (BMI`26.4) and normal visceral fat accumulation (Normal VF group); V/S ratio`0.4 in obese and VFA`100 cm 2 in non-obese. The criteria in obese subjects have been previously described 15 and those in non-obese subjects were determined by the estimation of visceral fat in healthy normal body weight control subjects without risk factors (the 95 percentile of the VFA in healthy male subjects was 100 cm 2 ). 25 
Clinical observations
Blood was drawn after an overnight fast. Serum cholesterol and triglyceride concentration were determined by enzymatic methods. High-density lipoprotein (HDL) cholesterol was also measured by an enzymatic method after heparin and calcium precipitation. Low-density lipoprotein (LDL) cholesterol was calculated by Friedewald's formula. 26 Serum lipid concentrations which were previously determined without diet therapy and any lipid-lowering agents, were used as baseline values and the concentrations which were measured at the start of the study in patients who had received diet and drug treatments were used as values during lipid-lowering treatment. A 75 g oral glucose tolerance test (OGTT) was performed, and blood samples were collected at 0, 30, 60 and 120 min for the determination of glucose and insulin concentrations. Plasma glucose was assayed by the glucose oxidase method, and insulin was assayed by double antibody radioimmunoassay. The sums of the glucose and insulin concentrations during the oral glucose tolerance test were calculated (S glucose and S insulin). Blood pressure was taken from the right arm using a mercury sphygmomanometer, after the subjects had rested in a sitting position for 15 min. The diastolic pressure was recorded when the Korotkoff sounds disappeared (phase ®ve).
Coronary angiography was performed by the Judkins percutaneous femoral artery technique. Angiograms were recorded in six and three projections for the left and right coronary arteries, respectively. All angiograms were visually reviewed by two independent expert cardiologists who were unaware of patients' clinical pro®les, including their fat distribution. The de®nition of coronary segments to be analyzed was based on the American Heart Association Reporting System. The coronary stenosis index was de®ned as the sum of the scores of the 15 segments of the main branch coronary arteries described by Mabuchi et al. 21 A normal coronary angiogram was graded 0, stenosis of less than 25% was graded 1, 25±50% stenosis was graded 2, 50±75% stenosis was graded 3, and more than 75% stenosis was graded 4. The location of coronary lesions was estimated as the percentage of stenotic segments over 50% stenosis in each of the proximal, middle, and distal segments. Segments #1, #5, #6, and #11 were de®ned as proximal segments; segments #2, #3, #7, #9, #12 were de®ned as middle segments; and segments #4, #8, #10, #13, #14, #15 were de®ned as distal segments. An ectasic segment was de®ned as one with a luminal diameter b1.5 times that of the adjacent normal segment. Poststenotic dilatation was excluded from this analysis.
Data analysis
Results were expressed as the mean values AE the standard deviation (s.d). The signi®cance of the differences between mean values of anthropometric and metabolic variables and blood pressures, which were normally distributed, for the high and normal VF groups was determined by the student's non-paired t-test. Comparison of several values (serum triglyceride, plasma insulin, S insulin during OGTT, diastolic blood pressure, and coronary stenosis index), which were not normally distributed, were performed by the Mann-Whitney test. Linear regression analysis was used to study the relationship between variances. Differences in the frequency of smoking habits, using lipid-lowering agents, cardiac events, coronary lesions in proximal, middle, and distal segments, and number of patients with coronary ectasia between the two groups were tested for signi®cance using the chisquare test. Multiple regression analysis was performed to quantify the effects of age, BMI, and subcutaneous fat area. A probability value P`0.05 was considered statistically signi®cant. Table 1 presents the mean values AE s.d. for the clinical, anthropometric, and metabolic variables and blood pressures of the high and normal VF groups. The high VF group tended to be older, but the difference was not statistically signi®cant (P 0.073). The mean values of BMI and subcutaneous fat area were signi®cantly higher in the high VF group. The mean value of ATT and the frequency of smoking habits were not signi®cantly different, but the high VF group had a tendency to have a higher frequency of smoking (P 0.081). The frequency of the patients using lipid-lowering agents and the dose of usage of them did not differ between the groups. Although baseline total serum cholesterol (T-Chol) concentrations were markedly high in both groups, there was no difference between these groups. Baseline serum triglyceride (TG) concentrations were signi®cantly increased in the high VF group. Baseline serum HDL cholesterol (HDL-C) was not signi®cantly different between the groups. The mean value of baseline LDL-cholesterol (LDL-C) level was signi®-cantly lower in the High VF group. Although the mean values of T-Chol, TG, HDL-C, and LDL-C levels during lipid-lowering treatment were not signi®cantly different between two groups, the reduction rate of LDL-C was signi®cantly decreased in the high VF group. Fasting plasma glucose (FPG) and insulin (FPI) and S glucose and S insulin during the OGTT were signi®cantly increased in the high VF group. Systolic and diastolic blood pressures (systolic BP and diastolic BP) were signi®cantly elevated in the high VF group. Figure 1 shows the relationship between the visceral fat area and the S glucose and S insulin during the OGTT in patients with FH. There were signi®cant correlations between the visceral fat area and S glucose (r 0.50; P`0.01) and S insulin (r 0.46; P`0.01). The coronary stenosis index was signi®- Importance of visceral fat accumulation in FH T Nakamura et al cantly increased in proportion to the increase in visceral fat area (r 0.46; P`0.01) (Figure 2 ). Table 2 shows the cardiac events, the severity and the location of coronary lesions and the prevalence of coronary ectasia in FH patients with normal and high visceral fat accumulation. Although the distribution of cardiac events including old myocardial infarction and angina pectoris or silent myocardial ischemia were not statistically different between the two groups, the frequency of old myocardial infarction tended to be higher in the high VF group (P 0.08). The mean value of the coronary stenosis index was signi®cantly higher in the high VF group than in the normal VF group. The frequency of stenotic lesions in the distal coronary arteries (segments #4, #8, #10, #14, #15) was signi®cantly higher in the high VF group than in the normal VF group (25.0% vs 5.2%, P`0.001). The prevalence of coronary ectasia was not different between the two groups. Furthermore, multiple regression analysis was undertaken to ascertain whether the visceral fat area had independent correlation with the coronary stenosis index. The coronary stenosis index correlated signi®cantly with the visceral fat area after adjustment for age, BMI, and subcutaneous fat area (Table 3 ). 
Results
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Discussion
This study has demonstrated intra-abdominal visceral fat accumulation is an important factor in the development of CAD in heterozygous FH. Hypercholesterolaemia has been known to be a major risk factor for atherosclerotic disease. 27, 28 FH is a representative disorder characterized by premature CAD caused by high LDL-cholesterol in the plasma. However, previous reports have reported other metabolic and environmental factors such as low HDL-cholesterolaemia, hypertriglyceridaemia, male gender, hypertension, smoking, and the degree of Achilles' tendon thickening to be closely related to the incidence of CAD in heterozygous FH. 29±33 Thus, multiple parameters other than serum cholesterol concentration should be considered when evaluating the atherogencitiy of FH patients. In recent years, several studies have shown that a clustering of multiple risk factors, including glucose intolerance, insulin resistance, hyperlipidaemia, and hypertension, correlate with the occurrence of atherosclerotic disease in non-FH subjects. 7, 8 It has also been found that intra-abdominal visceral fat estimated by computed tomography is the most important pathogenetic and etiologic factor responsible for these relationships. 20, 34 This study has found serum triglyceride, fasting plasma glucose, and insulin concentrations to be higher in the high VF group than in the normal VF group. Systolic and diastolic blood pressures in the high VF group were signi®cantly higher than those in the normal VF group. These results suggest that visceral fat accumulation may play an essential role in the appearance of multiple risk factors, even in FH patients. The sums of the plasma glucose and insulin levels during the oral glucose tolerance test were positively correlated with visceral fat area, suggesting that visceral fat accumulation may be related to insulin resistance. Recent studies have demonstrated that high LDL-cholesterol concentration caused by impaired LDL receptor activity did not cause insulin resistance in heterozygous FH. 35, 36 Accordingly, high LDL-cholesterol and insulin resistance may participate in the development of CAD independently in FH.
In this present study, we found the frequency of old myocardial infarction tended to be higher in the high VF group and the severity of coronary lesions was signi®cantly correlated with visceral fat area. Moreover, the frequency of the lesions in the distal segments of coronary arteries was signi®cantly higher in the high VF group. Although previous studies have reported that there were no signi®cant associations between coronary events or the severity of coronary lesions and other known risk factors, such as hypertension, glucose intolerance, and obesity in male FH, these studies were not examined from the points of the fat distribution and the clustering of risk factors. 21, 29 However, in this present study, we revealed a close correlation between visceral fat accumulation associated with multiple risk factors and severity of coronary lesions. Furthermore, this relationship was still signi®cant after adjustment of age, BMI, and subcutaneous fat area. These results suggest that à clustering' of these factors brought by visceral fat accumulation may be more important than that the severity of each factor is more or less. We also found that age and the frequency of smoking habits tended to be higher in the high VF group compared to those in the normal VF group. It was widely known that both ageing and smoking are potent risk factors for CAD. Although several studies including ours have demonstrated that ageing and smoking may increase visceral fat accumulation, these factors themselves might be related to the severity of coronary lesions in the high VF group. 37, 38 The number of subjects was comparatively small and only male subjects were investigated in this study. One reason for this limitation may be that the subjects were limited to patients being recruited by the indication of a coronary angiogram. Previous studies also demonstrated that gender difference should be considered to evaluate the atherogenicity in FH.
21,29±31
We should further evaluate the relationship between visceral fat accumulation and development of CAD in many more FH patients, including in female subjects. Moreover, another reasons for the close correlation may be that visceral fat tissue has a substantially different mode of action on atherosclerotic lesions than hypercholesterolaemia. As it is possible to effectively control plasma lipids in FH with several potent cholesterol-lowering agents, we evaluated the effect of lipid-lowering treatment on lipid concentrations between the groups. During the treatment, the lipid concentrations were not different between the groups, but the reduction rate of LDL-C was signi®cantly lower in the high VF group than that in the normal VF group. Accordingly, it may also be important to reduce the visceral fat accumulation to improve the ef®cacy of lipid-lowering agents in FH.
We observed that one of the characteristics of coronary atherosclerosis in the high VF group was a high incidence of lesions in the distal segments. The mechanism by which visceral fat accumulation causes distal coronary lesions is not clear. It has recently been proposed that insulin resistance or hyperinsulinaemia may induce coronary hypervasoconstriction and microvascular dysfunction. 39, 40 It has also been suggested that endothelial cell function may be impaired in non-stenotic systemic arteries in patients with FH. 41 It has also been shown that hypercholesterolaemia is associated with abnormal endothelium-dependent vasomotion in both the epicardial and resistance coronary arteries. 42, 43 Furthermore, Egashira et al 44 have recently shown that cholesterol-lowering treatment may improve endothelium-dependent coronary vasomotion in patients with hypercholesterolaemia. The distal segments of coronary arteries with endothelial cell damage may be partly caused by the impaired ef®cacy Importance of visceral fat accumulation in FH T Nakamura et al of the cholesterol lowering drugs when treating hypercholesterolaemia associated with visceral fat accumulation, and may be more easily affected by high vasomotor tone and microvascular dysfunction based on insulin resistance. Further studies are necessary to clarify this relationship. Both Genda et al 45 and Sudhir et al 46 have demonstrated that coronary ectasia is more prevalent (18 and 15%) in FH patients than in non-FH patients with CAD. We also demonstrated a high (20%) prevalence of ectasia in the FH patients similar to that in these studies. Although there was no difference in the prevalence of coronary ectasia between the high and normal VF groups, the patients with ectasia in the high VF group had multiple lesions that were associated with more severe stenoses in agreement with Sudhir et al. 46 Further observation is required to reveal the relationship between visceral fat accumulation and coronary ectasia in FH.
Conclusions
In this current study, it has been clearly demonstrated that visceral fat accumulation is a potent coronary risk factor in addition to hyper LDL-cholesterolaemia in FH patients. The assessment of intra-abdominal visceral fat accumulation should be considered when treating and predicting the development of CAD in FH patients.
